REPEAT TRANSPLANTS AND RISING INFECTIONS: KIDNEY TRANSPLANT COMPLICATIONS IN A HIGH VOLUME CENTRE IN NIGERIA

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
REPEAT TRANSPLANTS AND RISING INFECTIONS: KIDNEY TRANSPLANT COMPLICATIONS IN A HIGH VOLUME CENTRE IN NIGERIA

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Olalekan
Olatise
Olalekan Olatise oo.olatise@gmail.com Zenith Medical and Kidney Centre Department of Internal Medicine Abuja Nigeria *
Michael Muoka muokamichael@yahoo.com Zenith Medical and Kidney Centre Department of Clinical Research Abuja Nigeria -
Stephen Asaolu stephen.asaolu@gmail.com Zenith Medical and Kidney Centre Department of Clinical Research Abuja Nigeria - Sydani Institute for Research and Innovation, Sydani Group Research Abuja Nigeria
Ade Faponle eadegboyega@gmail.com Zenith Medical and Kidney Centre Department of Internal Medicine Abuja Nigeria -
Kudirat Busari quarkim213@gmail.com Zenith Medical and Kidney Centre Department of Internal Medicine Abuja Nigeria -
Abiodun Adeyemo adeyemowaliyullah@gmail.com Zenith Medical and Kidney Centre Department of Internal Medicine Abuja Nigeria -
Adaku Olatise drateeo@gmail.com Zenith Medical and Kidney Centre Department of Internal Medicine Abuja Nigeria -
Temitayo Oyewusi-Ojo temitayoojo58@gmail.com Zenith Medical and Kidney Centre Department of Clinical Research Abuja Nigeria -
Hyginus Ekwuazi hoekwuazi@gmail.com Zenith Medical and Kidney Centre Department of Surgery Abuja Nigeria -
-
-
-
-
-
-

Kidney transplantation is the preferred treatment for end-stage kidney disease (ESKD), offering better survival and quality of life compared to dialysis. However, post-kidney transplant complications pose a significant challenge in low-income countries, where access to specialized care, immunological monitoring, and infection control is often limited. Therefore, understanding the complication patterns and associated risk factors in our setting is critical to improving patient outcomes.

We conducted a retrospective review of 149 kidney transplant recipients managed at Zenith Medical and Kidney Centre, Abuja, Nigeria, between January and December 2024. Patient demographics, donor characteristics, and post-transplant outcomes were extracted and analyzed using SPSS version 27. Complication types and their associations were assessed using Chi-square tests.

Of the 149 kidney transplant recipients, 67.8% (n = 101) had no reported complications, while 11.4% (n = 17) developed sepsis or infections, 5.4% (n = 8) had allograft dysfunction, and 4.0% (n = 6) experienced hematologic complications. A statistically significant association was found between repeat transplantation and the occurrence of post-transplant complications (p < 0.001). There was no significant association between complications and recipient or donor age, sex, and exposure to  hepatitis C virus (HCV) or cytomegalovirus (CMV).

The majority of patients did not experience complications within the first year post-transplant. However, repeat kidney transplant was associated with a significantly higher risk of complications. Sepesis was the most frequently reported complication, indicating the need for stricter infection control measures in patients undergoing repeat kidney transplantation. Investing in infection surveillance and long-term patient monitoring may improve post-transplant outcomes in low-income countries.

Kewords